BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Baquero F, Lanza VF, Baquero MR, Del Campo R, Bravo-Vázquez DA. Microcins in Enterobacteriaceae: Peptide Antimicrobials in the Eco-Active Intestinal Chemosphere. Front Microbiol 2019;10:2261. [PMID: 31649628 DOI: 10.3389/fmicb.2019.02261] [Cited by in Crossref: 53] [Cited by in F6Publishing: 56] [Article Influence: 13.3] [Reference Citation Analysis]
Number Citing Articles
1 Kirundi J, Moghadamrad S, Urbaniak C. Microbiome-liver crosstalk: A multihit therapeutic target for liver disease. World J Gastroenterol 2023; 29(11): 1651-1668 [DOI: 10.3748/wjg.v29.i11.1651] [Reference Citation Analysis]
2 Campos-Madueno EI, Moradi M, Eddoubaji Y, Shahi F, Moradi S, Bernasconi OJ, Moser AI, Endimiani A. Intestinal colonization with multidrug-resistant Enterobacterales: screening, epidemiology, clinical impact, and strategies to decolonize carriers. Eur J Clin Microbiol Infect Dis 2023;42:229-54. [PMID: 36680641 DOI: 10.1007/s10096-023-04548-2] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Cesaro A, Lin S, Pardi N, de la Fuente-Nunez C. Advanced delivery systems for peptide antibiotics. Adv Drug Deliv Rev 2023;196:114733. [PMID: 36804008 DOI: 10.1016/j.addr.2023.114733] [Reference Citation Analysis]
4 Almeida MC, da Costa PM, Sousa E, Resende DISP. Emerging Target-Directed Approaches for the Treatment and Diagnosis of Microbial Infections. J Med Chem 2023;66:32-70. [PMID: 36586133 DOI: 10.1021/acs.jmedchem.2c01212] [Reference Citation Analysis]
5 Lee SM, Keum HL, Sul WJ. Bacterial Crosstalk via Antimicrobial Peptides on the Human Skin: Therapeutics from a Sustainable Perspective. J Microbiol 2023;61:1-11. [PMID: 36719618 DOI: 10.1007/s12275-022-00002-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Anne Sahithi S, Paulraj Gundupalli M, Shanmugam V, Sriariyanun M. Lantibiotics production—optimization and scale-up research: cutting edge and challenges. Lantibiotics as Alternative Therapeutics 2023. [DOI: 10.1016/b978-0-323-99141-4.00020-5] [Reference Citation Analysis]
7 Borgonovi TF, Salgaço MK, Oliveira GLV, Carvalho LAL, Pinheiro DG, Todorov SD, Sivieri K, Casarotti SN, Penna ALB. Functional Fermented Milk with Fruit Pulp Modulates the In Vitro Intestinal Microbiota. Foods 2022;11. [PMID: 36553855 DOI: 10.3390/foods11244113] [Reference Citation Analysis]
8 Cole TJ, Parker JK, Feller AL, Wilke CO, Davies BW. Evidence for Widespread Class II Microcins in Enterobacterales Genomes. Appl Environ Microbiol 2022;88:e0148622. [PMID: 36394322 DOI: 10.1128/aem.01486-22] [Reference Citation Analysis]
9 Huo Y, Jiang Q, Zhao W. Meta-analysis of metagenomics reveals the signatures of vaginal microbiome in preterm birth. Medicine in Microecology 2022;14:100065. [DOI: 10.1016/j.medmic.2022.100065] [Reference Citation Analysis]
10 Mortzfeld BM, Palmer JD, Bhattarai SK, Dupre HL, Mercado-Lubio R, Silby MW, Bang C, McCormick BA, Bucci V. Microcin MccI47 selectively inhibits enteric bacteria and reduces carbapenem-resistant Klebsiella pneumoniae colonization in vivo when administered via an engineered live biotherapeutic. Gut Microbes 2022;14:2127633. [PMID: 36175830 DOI: 10.1080/19490976.2022.2127633] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Ongpipattanakul C, Desormeaux EK, DiCaprio A, van der Donk WA, Mitchell DA, Nair SK. Mechanism of Action of Ribosomally Synthesized and Post-Translationally Modified Peptides. Chem Rev 2022;122:14722-814. [PMID: 36049139 DOI: 10.1021/acs.chemrev.2c00210] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
12 Marković KG, Grujović MŽ, Koraćević MG, Nikodijević DD, Milutinović MG, Semedo-Lemsaddek T, Djilas MD. Colicins and Microcins Produced by Enterobacteriaceae: Characterization, Mode of Action, and Putative Applications. Int J Environ Res Public Health 2022;19. [PMID: 36142096 DOI: 10.3390/ijerph191811825] [Reference Citation Analysis]
13 Dicks LMT, Vermeulen W. Do Bacteria Provide an Alternative to Cancer Treatment and What Role Does Lactic Acid Bacteria Play? Microorganisms 2022;10:1733. [DOI: 10.3390/microorganisms10091733] [Reference Citation Analysis]
14 Kuznetsova MV, Mihailovskaya VS, Remezovskaya NB, Starčič Erjavec M. Bacteriocin-Producing Escherichia coli Isolated from the Gastrointestinal Tract of Farm Animals: Prevalence, Molecular Characterization and Potential for Application. Microorganisms 2022;10:1558. [DOI: 10.3390/microorganisms10081558] [Reference Citation Analysis]
15 Imran M, Ahmad MN, Dasgupta A, Rana P, Srinivas N, Chopra S. Novel approaches for the treatment of infections due to multidrug-resistant bacterial pathogens. Future Med Chem 2022. [PMID: 35861021 DOI: 10.4155/fmc-2022-0029] [Reference Citation Analysis]
16 Thakur A, Sharma A, Alajangi HK, Jaiswal PK, Lim YB, Singh G, Barnwal RP. In pursuit of next-generation therapeutics: Antimicrobial peptides against superbugs, their sources, mechanism of action, nanotechnology-based delivery, and clinical applications. Int J Biol Macromol 2022;218:135-56. [PMID: 35868409 DOI: 10.1016/j.ijbiomac.2022.07.103] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
17 Telhig S, Ben Said L, Torres C, Rebuffat S, Zirah S, Fliss I. Evaluating the Potential and Synergetic Effects of Microcins against Multidrug-Resistant Enterobacteriaceae. Microbiol Spectr 2022;:e0275221. [PMID: 35543514 DOI: 10.1128/spectrum.02752-21] [Reference Citation Analysis]
18 Parker JK, Davies BW. Microcins reveal natural mechanisms of bacterial manipulation to inform therapeutic development. Microbiology (Reading) 2022;168. [PMID: 35438625 DOI: 10.1099/mic.0.001175] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Baquero F, del Campo R, Martínez J. Interventions in Nicotinamide Adenine Dinucleotide Metabolism, the Intestinal Microbiota and Microcin Peptide Antimicrobials. Front Mol Biosci 2022;9:861603. [DOI: 10.3389/fmolb.2022.861603] [Reference Citation Analysis]
20 Hashem I, Van Impe JFM. A Game Theoretic Analysis of the Dual Function of Antibiotics. Front Microbiol 2021;12:812788. [PMID: 35250912 DOI: 10.3389/fmicb.2021.812788] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Suissa R, Oved R, Jankelowitz G, Turjeman S, Koren O, Kolodkin-Gal I. Molecular genetics for probiotic engineering: dissecting lactic acid bacteria. Trends Microbiol 2022;30:293-306. [PMID: 34446338 DOI: 10.1016/j.tim.2021.07.007] [Cited by in Crossref: 18] [Cited by in F6Publishing: 5] [Article Influence: 18.0] [Reference Citation Analysis]
22 Lynch JP, Goers L, Lesser CF. Emerging strategies for engineering Escherichia coli Nissle 1917-based therapeutics. Trends in Pharmacological Sciences 2022. [DOI: 10.1016/j.tips.2022.02.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
23 Chen H(, Ma Z(. Further Quantifying the Niche-Neutral Continuum of Human Digestive Tract Microbiomes with Near Neutral Model and Stochasticity Analysis. Evol Bioinform Online 2022;18:117693432211285. [DOI: 10.1177/11769343221128540] [Reference Citation Analysis]
24 Slack E, Diard M. Resistance is futile? Mucosal immune mechanisms in the context of microbial ecology and evolution. Mucosal Immunol 2022;15:1188-98. [PMID: 36329192 DOI: 10.1038/s41385-022-00574-z] [Reference Citation Analysis]
25 Fuertes-Perez S, Vogel RF, Hilgarth M. Comparative genomics of Photobacterium species from terrestrial and marine habitats. Curr Res Microb Sci 2021;2:100087. [PMID: 34950912 DOI: 10.1016/j.crmicr.2021.100087] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
26 Baquero F, Saralegui C, Marcos-Mencía D, Ballestero L, Vañó-Galván S, Moreno-Arrones ÓM, Del Campo R. Epidermis as a Platform for Bacterial Transmission. Front Immunol 2021;12:774018. [PMID: 34925344 DOI: 10.3389/fimmu.2021.774018] [Reference Citation Analysis]
27 Mortzfeld BM, Palmer JD, Bhattarai SK, Dupre HL, Mercado-lubo R, Silby MW, Bang C, Mccormick BA, Bucci V. Microcin MccI47 selectively inhibits enteric bacteria and reduces carbapenem-resistant Klebsiella pneumoniae colonization in vivo when administered via an engineered live biotherapeutic.. [DOI: 10.1101/2021.12.17.473159] [Reference Citation Analysis]
28 Oulas A, Zachariou M, Chasapis CT, Tomazou M, Ijaz UZ, Schmartz GP, Spyrou GM, Vlamis-Gardikas A. Putative Antimicrobial Peptides Within Bacterial Proteomes Affect Bacterial Predominance: A Network Analysis Perspective. Front Microbiol 2021;12:752674. [PMID: 34867874 DOI: 10.3389/fmicb.2021.752674] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
29 Diale MO, Kayitesi E, Serepa-Dlamini MH. Genome In Silico and In Vitro Analysis of the Probiotic Properties of a Bacterial Endophyte, Bacillus Paranthracis Strain MHSD3. Front Genet 2021;12:672149. [PMID: 34858466 DOI: 10.3389/fgene.2021.672149] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
30 Rebuffat S. Ribosomally synthesized peptides, foreground players in microbial interactions: recent developments and unanswered questions. Nat Prod Rep 2021. [PMID: 34755755 DOI: 10.1039/d1np00052g] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
31 Frimodt-Møller J, Campion C, Nielsen PE, Løbner-Olesen A. Translocation of non-lytic antimicrobial peptides and bacteria penetrating peptides across the inner membrane of the bacterial envelope. Curr Genet 2021. [PMID: 34750687 DOI: 10.1007/s00294-021-01217-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
32 Heilbronner S, Krismer B, Brötz-Oesterhelt H, Peschel A. The microbiome-shaping roles of bacteriocins. Nat Rev Microbiol 2021;19:726-39. [PMID: 34075213 DOI: 10.1038/s41579-021-00569-w] [Cited by in Crossref: 57] [Cited by in F6Publishing: 55] [Article Influence: 28.5] [Reference Citation Analysis]
33 Lu S, Skory CD, El Enshasy HA, Liu S. Fermentative production of alternative antimicrobial peptides and enzymes. Biocatalysis and Agricultural Biotechnology 2021;37:102189. [DOI: 10.1016/j.bcab.2021.102189] [Reference Citation Analysis]
34 Gatsios A, Kim CS, Crawford JM. Escherichia coli small molecule metabolism at the host-microorganism interface. Nat Chem Biol 2021;17:1016-26. [PMID: 34552219 DOI: 10.1038/s41589-021-00807-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
35 Sibinelli-Sousa S, de Araújo-Silva AL, Hespanhol JT, Bayer-Santos E. Revisiting the steps of Salmonella gut infection with a focus on antagonistic interbacterial interactions. FEBS J 2021. [PMID: 34546626 DOI: 10.1111/febs.16211] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
36 Le Guern R, Stabler S, Gosset P, Pichavant M, Grandjean T, Faure E, Karaca Y, Faure K, Kipnis E, Dessein R. Colonization resistance against multi-drug-resistant bacteria: a narrative review. J Hosp Infect 2021;118:48-58. [PMID: 34492304 DOI: 10.1016/j.jhin.2021.09.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
37 Perreau J, Moran NA. Genetic innovations in animal-microbe symbioses. Nat Rev Genet 2021. [PMID: 34389828 DOI: 10.1038/s41576-021-00395-z] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 8.0] [Reference Citation Analysis]
38 Nawrocki EM, Hutchins LE, Eaton KA, Dudley EG. Mcc1229, an Stx2a-amplifying microcin, is produced in vivo and requires CirA for activity.. [DOI: 10.1101/2021.07.19.453020] [Reference Citation Analysis]
39 Baquero F, Martínez JL, F Lanza V, Rodríguez-Beltrán J, Galán JC, San Millán A, Cantón R, Coque TM. Evolutionary Pathways and Trajectories in Antibiotic Resistance. Clin Microbiol Rev 2021;:e0005019. [PMID: 34190572 DOI: 10.1128/CMR.00050-19] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 9.5] [Reference Citation Analysis]
40 Cesa-Luna C, Alatorre-Cruz JM, Carreño-López R, Quintero-Hernández V, Baez A. Emerging Applications of Bacteriocins as Antimicrobials, Anticancer Drugs, and Modulators of The Gastrointestinal Microbiota. Pol J Microbiol 2021;70:143-59. [PMID: 34349808 DOI: 10.33073/pjm-2021-020] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
41 Balko O, Zabolotny Institute of Microbiology and Virology, NAS of Ukraine. Interaction between S-Type Pyocins and Microcin-II-Like Bacteriocins in Pseudomonas aeruginosa. Mikrobiol Z 2021;83:72-80. [DOI: 10.15407/microbiolj83.03.072] [Reference Citation Analysis]
42 Kolodiazhnyi OI. Phosphorus Compounds of Natural Origin: Prebiotic, Stereochemistry, Application. Symmetry 2021;13:889. [DOI: 10.3390/sym13050889] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
43 Gradisteanu Pircalabioru G, Popa LI, Marutescu L, Gheorghe I, Popa M, Czobor Barbu I, Cristescu R, Chifiriuc MC. Bacteriocins in the Era of Antibiotic Resistance: Rising to the Challenge. Pharmaceutics 2021;13:196. [PMID: 33540560 DOI: 10.3390/pharmaceutics13020196] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 9.0] [Reference Citation Analysis]
44 Song L, Pan J, Yang Y, Zhang Z, Cui R, Jia S, Wang Z, Yang C, Xu L, Dong TG, Wang Y, Shen X. Contact-independent killing mediated by a T6SS effector with intrinsic cell-entry properties. Nat Commun 2021;12:423. [PMID: 33462232 DOI: 10.1038/s41467-020-20726-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
45 Sharma P, Tiwari SK. Bacteriocins of Probiotics as Potent Anticancer Agents. Probiotic Research in Therapeutics 2021. [DOI: 10.1007/978-981-15-8214-1_11] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
46 Johanns VC, Epping L, Semmler T, Ghazisaeedi F, Lübke-Becker A, Pfeifer Y, Eichhorn I, Merle R, Bethe A, Walther B, Wieler LH. High-Zinc Supplementation of Weaned Piglets Affects Frequencies of Virulence and Bacteriocin Associated Genes Among Intestinal Escherichia coli Populations. Front Vet Sci 2020;7:614513. [PMID: 33392299 DOI: 10.3389/fvets.2020.614513] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
47 Baquero F, F Lanza V, Duval M, Coque TM. Ecogenetics of antibiotic resistance in Listeria monocytogenes. Mol Microbiol 2020;113:570-9. [PMID: 32185838 DOI: 10.1111/mmi.14454] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 8.7] [Reference Citation Analysis]
48 Telhig S, Ben Said L, Zirah S, Fliss I, Rebuffat S. Bacteriocins to Thwart Bacterial Resistance in Gram Negative Bacteria. Front Microbiol 2020;11:586433. [PMID: 33240239 DOI: 10.3389/fmicb.2020.586433] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 9.0] [Reference Citation Analysis]
49 Agarwal A, Agashe D. The red flour beetle Tribolium castaneum: A model for host-microbiome interactions. PLoS One 2020;15:e0239051. [PMID: 33006995 DOI: 10.1371/journal.pone.0239051] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
50 Cheng C, Hua ZC. Lasso Peptides: Heterologous Production and Potential Medical Application. Front Bioeng Biotechnol 2020;8:571165. [PMID: 33117783 DOI: 10.3389/fbioe.2020.571165] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
51 Bosák J, Hrala M, Micenková L, Šmajs D. Non-antibiotic antibacterial peptides and proteins of Escherichia coli: efficacy and potency of bacteriocins. Expert Rev Anti Infect Ther 2021;19:309-22. [PMID: 32856960 DOI: 10.1080/14787210.2020.1816824] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
52 Zimina M, Babich O, Prosekov A, Sukhikh S, Ivanova S, Shevchenko M, Noskova S. Overview of Global Trends in Classification, Methods of Preparation and Application of Bacteriocins. Antibiotics (Basel) 2020;9:E553. [PMID: 32872235 DOI: 10.3390/antibiotics9090553] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 10.7] [Reference Citation Analysis]
53 Zhang K, Li X, Yu C, Wang Y. Promising Therapeutic Strategies Against Microbial Biofilm Challenges. Front Cell Infect Microbiol 2020;10:359. [PMID: 32850471 DOI: 10.3389/fcimb.2020.00359] [Cited by in Crossref: 39] [Cited by in F6Publishing: 43] [Article Influence: 13.0] [Reference Citation Analysis]
54 Mazurek-Popczyk J, Pisarska J, Bok E, Baldy-Chudzik K. Antibacterial Activity of Bacteriocinogenic Commensal Escherichia coli against Zoonotic Strains Resistant and Sensitive to Antibiotics. Antibiotics (Basel) 2020;9:E411. [PMID: 32679778 DOI: 10.3390/antibiotics9070411] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
55 Naimi S, Zirah S, Taher MB, Theolier J, Fernandez B, Rebuffat SF, Fliss I. Microcin J25 Exhibits Inhibitory Activity Against Salmonella Newport in Continuous Fermentation Model Mimicking Swine Colonic Conditions. Front Microbiol 2020;11:988. [PMID: 32528437 DOI: 10.3389/fmicb.2020.00988] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
56 Meade E, Slattery MA, Garvey M. Bacteriocins, Potent Antimicrobial Peptides and the Fight against Multi Drug Resistant Species: Resistance Is Futile? Antibiotics (Basel) 2020;9:E32. [PMID: 31963311 DOI: 10.3390/antibiotics9010032] [Cited by in Crossref: 114] [Cited by in F6Publishing: 117] [Article Influence: 38.0] [Reference Citation Analysis]
57 Maslennikova I, Gizatullina J, Afanasievskaya E, Starčič Erjavec M, Kuznetsova M, Loretts O, Ojha N, Vinogradov S, Ruchkin A, Kukhar V. Probiotic potential of Escherichia coli ŽP for the gut microbiota of chickens. E3S Web of Conf 2020;222:03021. [DOI: 10.1051/e3sconf/202022203021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
58 Bueno J. Synergy and Antagonism: The Criteria of the Formulation. Nanotechnology in the Life Sciences 2020. [DOI: 10.1007/978-3-030-43855-5_3] [Reference Citation Analysis]
59 Paquette SJ, Reuter T. Properties of an Antimicrobial Molecule Produced by an Escherichia coli Champion. Antibiotics (Basel) 2019;9:E6. [PMID: 31877806 DOI: 10.3390/antibiotics9010006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
60 Baquero F, Coque TM, Martínez JL, Aracil-Gisbert S, Lanza VF. Gene Transmission in the One Health Microbiosphere and the Channels of Antimicrobial Resistance. Front Microbiol 2019;10:2892. [PMID: 31921068 DOI: 10.3389/fmicb.2019.02892] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 9.0] [Reference Citation Analysis]